|
?:abstract
|
-
BACKGROUND: Specific diagnostic tests to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and resulting COVID-19 disease are not always available and take time to obtain results. Routine laboratory markers such as white blood cell count, measures of anticoagulation, C-reactive protein (CRP) and procalcitonin, are used to assess the clinical status of a patient. These laboratory tests may be useful for the triage of people with potential COVID-19 to prioritize them for different levels of treatment, especially in situations where time and resources are limited. OBJECTIVES: To assess the diagnostic accuracy of routine laboratory testing as a triage test to determine if a person has COVID-19. SEARCH METHODS: On 4 May 2020 we undertook electronic searches in the Cochrane COVID-19 Study Register and the COVID-19 Living Evidence Database from the University of Bern, which is updated daily with published articles from PubMed and Embase and with preprints from medRxiv and bioRxiv. In addition, we checked repositories of COVID-19 publications. We did not apply any language restrictions. SELECTION CRITERIA: We included both case-control designs and consecutive series of patients that assessed the diagnostic accuracy of routine laboratory testing as a triage test to determine if a person has COVID-19. The reference standard could be reverse transcriptase polymerase chain reaction (RT-PCR) alone; RT-PCR plus clinical expertise or and imaging; repeated RT-PCR several days apart or from different samples; WHO and other case definitions; and any other reference standard used by the study authors. DATA COLLECTION AND ANALYSIS: Two review authors independently extracted data from each included study. They also assessed the methodological quality of the studies, using QUADAS-2. We used the \'NLMIXED\' procedure in SAS 9.4 for the hierarchical summary receiver operating characteristic (HSROC) meta-analyses of tests for which we included four or more studies. To facilitate interpretation of results, for each meta-analysis we estimated summary sensitivity at the points on the SROC curve that corresponded to the median and interquartile range boundaries of specificities in the included studies. MAIN RESULTS: We included 21 studies in this review, including 14,126 COVID-19 patients and 56,585 non-COVID-19 patients in total. Studies evaluated a total of 67 different laboratory tests. Although we were interested in the diagnotic accuracy of routine tests for COVID-19, the included studies used detection of SARS-CoV-2 infection through RT-PCR as reference standard. There was considerable heterogeneity between tests, threshold values and the settings in which they were applied. For some tests a positive result was defined as a decrease compared to normal vaues, for other tests a positive result was defined as an increase, and for some tests both increase and decrease may have indicated test positivity. None of the studies had either low risk of bias on all domains or low concerns for applicability for all domains. Only three of the tests evaluated had a summary sensitivity and specificity over 50%. These were: increase in interleukin-6, increase in C-reactive protein and lymphocyte count decrease. Blood count Eleven studies evaluated a decrease in white blood cell count, with a median specificity of 93% and a summary sensitivity of 25% (95% CI 8.0% to 27%; very low-certainty evidence). The 15 studies that evaluated an increase in white blood cell count had a lower median specificity and a lower corresponding sensitivity. Four studies evaluated a decrease in neutrophil count. Their median specificity was 93%, corresponding to a summary sensitivity of 10% (95% CI 1.0% to 56%; low-certainty evidence). The 11 studies that evaluated an increase in neutrophil count had a lower median specificity and a lower corresponding sensitivity. The summary sensitivity of an increase in neutrophil percentage (4 studies) was 59% (95% CI 1.0% to 100%) at median specificity (38%; very low-certainty evidence). The summary sensitivity of an increase in monocyte count (4 studies) was 13% (95% CI 6.0% to 26%) at median specificity (73%; very low-certainty evidence). The summary sensitivity of a decrease in lymphocyte count (13 studies) was 64% (95% CI 28% to 89%) at median specificity (53%; low-certainty evidence). Four studies that evaluated a decrease in lymphocyte percentage showed a lower median specificity and lower corresponding sensitivity. The summary sensitivity of a decrease in platelets (4 studies) was 19% (95% CI 10% to 32%) at median specificity (88%; low-certainty evidence). Liver function tests The summary sensitivity of an increase in alanine aminotransferase (9 studies) was 12% (95% CI 3% to 34%) at median specificity (92%; low-certainty evidence). The summary sensitivity of an increase in aspartate aminotransferase (7 studies) was 29% (95% CI 17% to 45%) at median specificity (81%) (low-certainty evidence). The summary sensitivity of a decrease in albumin (4 studies) was 21% (95% CI 3% to 67%) at median specificity (66%; low-certainty evidence). The summary sensitivity of an increase in total bilirubin (4 studies) was 12% (95% CI 3.0% to 34%) at median specificity (92%; very low-certainty evidence). Markers of inflammation The summary sensitivity of an increase in CRP (14 studies) was 66% (95% CI 55% to 75%) at median specificity (44%; very low-certainty evidence). The summary sensitivity of an increase in procalcitonin (6 studies) was 3% (95% CI 1% to 19%) at median specificity (86%; very low-certainty evidence). The summary sensitivity of an increase in IL-6 (four studies) was 73% (95% CI 36% to 93%) at median specificity (58%) (very low-certainty evidence). Other biomarkers The summary sensitivity of an increase in creatine kinase (5 studies) was 11% (95% CI 6% to 19%) at median specificity (94%) (low-certainty evidence). The summary sensitivity of an increase in serum creatinine (four studies) was 7% (95% CI 1% to 37%) at median specificity (91%; low-certainty evidence). The summary sensitivity of an increase in lactate dehydrogenase (4 studies) was 25% (95% CI 15% to 38%) at median specificity (72%; very low-certainty evidence). AUTHORS\' CONCLUSIONS: Although these tests give an indication about the general health status of patients and some tests may be specific indicators for inflammatory processes, none of the tests we investigated are useful for accurately ruling in or ruling out COVID-19 on their own. Studies were done in specific hospitalized populations, and future studies should consider non-hospital settings to evaluate how these tests would perform in people with milder symptoms.
-
Background Specific diagnostic tests to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and resulting COVID-19 disease are not always available and take time to obtain results Routine laboratory markers such as white blood cell count, measures of anticoagulation, C-reactive protein (CRP) and procalcitonin, are used to assess the clinical status of a patient These laboratory tests may be useful for the triage of people with potential COVID-19 to prioritize them for different levels of treatment, especially in situations where time and resources are limited Objectives To assess the diagnostic accuracy of routine laboratory testing as a triage test to determine if a person has COVI D-19 Search methods On 4 May 2020 we undertook electronic searches in the Cochrane COVID-19 Study Register and the COVID-19 Living Evidence Database from the University of Bern, which is updated daily with published articles from PubMed and Embase and with preprints from medRxiv and bioRxiv In addition, we checked repositories of COVID-19 publications We did not apply any language restrictions Selection criteria We incLuded both case -control designs and consecutive series of patients that assessed the diagnostic accuracy of routine Laboratory testing as a triage test to determine if a person has COVID-19 The reference standard could be reverse transcriptase polymerase chain reaction (RT-PCR) alone;RT-PCR pLus clinical expertise or and imaging;repeated RT-PCR several days apart or from different samples;WHO and other case definitions;and any other reference standard used by the study authors Data collection and analysis Two review authors independently extracted data from each included study They also assessed the methodologicaLquaLity of the studies, using QUADAS-2 We used the \'NLMIXED\' procedure in SAS 9 4 forthe hierarchical summary receiver operating characteristic (HSROC) meta analyses of tests for which we included four or more studies To facilitate interpretation of resuLts, for each meta-ana Lysis we estimated summary sensitivity at the points on the SROC curve that corresponded to the median and interquartile range boundaries of specificities in the included studies Main results We included 21 studies in this review, including 14,126 COVI D-19 patients and 56,585 non-COVID-19 patients in total Studies evaluated a total of 67 different laboratory tests Although we were interested in the diagnotic accuracy of routine tests for COVID-19, the included studies used detection of SARS-CoV-2 infection through RT-PCR as reference standard There was considerable heterogeneity between tests, threshold values and the settings in which they were applied For some tests a positive result was defined as a decrease compared to normal vaues, for other tests a positive result was defined as an increase, and for some tests both increase and decrease may have indicated test positivity None of the studies had either Low risk of bias on aLl domains or low concerns for applicabiLity for all domains Only three of the tests evaluated had a summary sensitivity and specificity over 50% These were: increase in interleu kin -6, increase in Creactive protein and lymphocyte count decrease Blood count Eleven studies evaluated a decrease in white blood cell count, with a median specificity of 930/0 and a summary sensitivity of 25% (95% Cl 8 0% to 27%;very low -certainty evidence) The 15 studies that evaluated an increase in white blood cell count had a lower median specificity and a lower corresponding sensitivity Four studies evaluated a decrease in neutrophil count Their median specificity was 93%, corresponding to a summary sensitivity of 10% (95% C11 00/0 to 56%;low -certainty evidence) The 11 studies that eva Luated an increase in neutrophil count had a lower median specificity and a lovver corresponding sensitivity The summary sensitivity of an increase in neutrophil percentage (4 studies) was 59% (95% CI 1 00/0 to 1000/0) at median specificity (38%;very low-certainty evidence) The summary sensitivity of an increase in monocyte count (4 studies) was 13% (95% CI 6 0% to 26%) at median specificity (73%;very low -certainty evidence) The summary sensitivity of a decrease in lymphocyte count (13 studies) was 640/0 (950/0 CI 28% to 890/0) at median specificity (530/0;low-certainty evidence) Four studies that evaluated a decrease in lymphocyte percentage showed a lower median specificity and lower corresponding sensitivity The summary sensitivity of a decrease in pLatelets (4 studies) was 19% (9590 CI 10% to 320/0) at median specificity (88%;Low certainty evidence) Liver function tests The summary sensitivity of an increase in alanine aminotransferase (9 studies) was 120/0 (95% CI 3% to 34%) at median specificity (92%;low -certainty evidence) The summary sensitivity of an increase in aspartate aminotransferase (7 studies) was 290/0 (950/0 CI 170/0 to 45%) at median specificity (810/0) (low -certainty evidence) The summary sensitivity of a decrease in aLbumin (4 studies) was 21% (95% CI 3% to 67%) at median specificity (66%;low -certainty evidence) The summary sensitivity of an increase in total bilirubin (4 studies) was 12% (95% Cl 3 0% to 340/0) at median specificity (92%;very low -certainty evidence) Markers of inflammation The summary sensitivity of an increase in CRP (14 studies) was 66% (95% CI 55% to 75%) at median specificity (440/0;very low-certainty evidence) The summary sensitivity of an increase in procaLcitonin (6 studies) was 3% (95% C11% to 19%) at median specificity (86%;very low -certainty evidence) The summary sensitivity of an increase in IL-6 (four studies) was 73% (95% CI 36% to 93%) at median specificity (58%) (very low -certainty evidence) Other biomarkers The summary sensitivity of an increase in creatine kinase (5 studies) was 11% (95% CI 60/0 to 190/0) at median specificity (94%) (low -certainty evidence) The summary sensitivity of an increase in serum creatinine (four studies) was 7% (95% CI 10/0 to 37%) at median specificity (91%;low -certainty evidence) The summary sensitivity of an increase in lactate dehydrogenase (4 studies) was 25% (95% CI 15% to 38%) at median specificity (72%;very low -certainty evidence) Authors\' conclusions Although these tests give an indication about the general health status of patients and some tests may be specific indicators for inflammatory processes, none of the tests we investigated are useful for accurately ruling in or ruling out COVI D-19 on their own Studies were done in specific hospitalized populations, and future studies should consider non -hospital settings to evaluate how these tests would perform in people with milder symptoms
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}